Kyle; Dennis E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kyle; Dennis E..The latest application filed is for "epigenetic modification of fungi and uses thereof".

Company Profile

8.18.15

Kyle; Dennis E. - Athens GA
Kyle; Dennis E. - Tampa FL US
KYLE; DENNIS E. - LITHIA FL
Kyle; Dennis E. - Gaithersburg MD
Kyle; Dennis E. - Fig Tree Pocket AU
Kyle, Dennis E. - US
Kyle; Dennis E. - Silver Spring MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Epigenetic Modification Of Fungi And Uses Thereof App 20220136019 - Baker; Bill J. ; et al.	2022-05-05
Treatment Of Acanthamoeba Or Balamuthia Trophozoites And/or Cysts App 20220096441 - Boykin; David W. ; et al.	2022-03-31
Leishmania inhibitors Grant 10,898,460 - Baker , et al. January 26, 2	2021-01-26
Antimicrobials from an epigenetics based fungal metabolite screening program Grant 10,377,733 - Demers , et al. A	2019-08-13
Antimicrobials from an epigenetics based fungal metabolite screening program Grant 10,358,431 - Demers , et al. July 23, 2	2019-07-23
Compounds And Methods For Their Use In The Treatment Of Malaria App 20190031613 - MANETSCH; ROMAN ; et al.	2019-01-31
Antimicrobials from an epigenetics based fungal metabolite screening program Grant 10,144,719 - Demers , et al. De	2018-12-04
Quinolone-based compounds, formulations, and uses thereof Grant 10,000,452 - Manetsch , et al. June 19, 2	2018-06-19
Diterpenoid membranolide compounds having anti-leishmania activity and uses thereof Grant 9,872,849 - Baker , et al. January 23, 2	2018-01-23
Diterpenoid Membranolide Compounds Having Anti-leishmania Activity And Uses Thereof App 20160030388 - BAKER; BILL J. ; et al.	2016-02-04
Novel Antiviral Compounds From Marine Extracts App 20140274883 - VAN OLPHEN; Alberto ; et al.	2014-09-18
Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith Grant 8,012,987 - Pitzer , et al. September 6, 2	2011-09-06
Novel Antiviral Compounds From Marine Extracts App 20110189221 - van Olphen; Alberto ; et al.	2011-08-04
Polyacrylate Nanoparticle Drug Delivery App 20100278920 - Turos; Edward ; et al.	2010-11-04
Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith App 20060160827 - Pitzer; Kevin K. ; et al.	2006-07-20
Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof Grant 6,906,098 - Solaja , et al. June 14, 2	2005-06-14
Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof Grant 6,800,618 - Lin , et al. October 5, 2	2004-10-05
Fab I and inhibition of apicomplexan parasites App 20040137446 - McLeod, Rima ; et al.	2004-07-15
Mixed steroidal 1, 2, 4, 5- tetraoxane compounds and methods of making and using thereof App 20040019200 - Solaja, Bogdan ; et al.	2004-01-29
Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith App 20030191138 - Pitzer, Kevin K. ; et al.	2003-10-09
Indolo[2,1-b] quinazole-6, 12-dione antimalarial compounds and methods of treating malaria therewith Grant 6,531,487 - Pitzer , et al. March 11, 2	2003-03-11
Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof App 20030032801 - Lin, Ai J. ; et al.	2003-02-13
Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith App 20010034350 - Pitzer, Kevin K. ; et al.	2001-10-25
Method for the treatment of malaria Grant 5,206,236 - Tidwell , et al. April 27, 1	1993-04-27
Method for treating leishmaniasis Grant 5,202,320 - Tidwell , et al. April 13, 1	1993-04-13

Company Registrations

NCAGE Code	4F7K8	KYLE DENNIS E
CAGE Code	4F7K8	KYLE, DENNIS E
DUNS	613707384	KYLE, DENNIS E

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.